Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gregory R, Chiklis"'
Autor:
Weiming Xia, Mingfei Li, Ying Wang, Lewis E. Kazis, Kim Berlo, Noureddine Melikechi, Gregory R. Chiklis
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Determining the sustainability of antibodies targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for predicting immune response against the Coronavirus disease 2019 (COVID-19). To quantify the antibody decay r
Externí odkaz:
https://doaj.org/article/f32bbc5fac4d4f68be1005417f9bcec9
Autor:
Maggie, Li, Evan J, Beck, Oliver, Laeyendecker, Yolanda, Eby, Aaron Ar, Tobian, Patrizio, Caturegli, Camille, Wouters, Gregory R, Chiklis, William, Block, Robert, McKie, Michael, Joyner, Timothy D, Wiltshire, Allan B, Dietz, Thomas J, Gniadek, Arell, Shapiro, Anusha, Yarava, Karen, Lane, Daniel, Hanley, Evan M, Bloch, Shmuel, Shoham, Edward R, Cachay, Barry R, Meisenberg, Moises A, Huaman, Yuriko, Fukuta, Bela, Patel, Sonya L, Heath, Adam C, Levine, James H, Paxton, Shweta, Anjan, Jonathan M, Gerber, Kelly A, Gebo, Arturo, Casadevall, Andrew, Pekosz, David J, Sullivan
The ongoing evolution of SARS-Co-V2 variants to omicron severely limits available effective monoclonal antibody therapies. Effective drugs are also supply limited. Covid-19 convalescent plasma (CCP) qualified for high antibody levels effectively redu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6199d9acbccaa1d265935e09706859a2
https://doi.org/10.1101/2022.03.01.22271662
https://doi.org/10.1101/2022.03.01.22271662
Autor:
Maggie Li, Evan J. Beck, Oliver Laeyendecker, Yolanda Eby, Aaron A. R. Tobian, Patrizio Caturegli, Camille Wouters, Gregory R. Chiklis, William Block, Robert O. McKie, Michael J. Joyner, Timothy D. Wiltshire, Allan B. Dietz, Thomas J. Gniadek, Arell J. Shapiro, Anusha Yarava, Karen Lane, Daniel F. Hanley, Evan M. Bloch, Shmuel Shoham, Edward R. Cachay, Barry R. Meisenberg, Moises A. Huaman, Yuriko Fukuta, Bela Patel, Sonya L. Heath, Adam C. Levine, James H. Paxton, Shweta Anjan, Jonathan M. Gerber, Kelly A. Gebo, Arturo Casadevall, Andrew Pekosz, David J. Sullivan
Publikováno v:
Blood advances. 6(12)
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants severely limits available effective monoclonal antibody therapies. Effective drugs are also supply limited. COVID-19 convalescent plasma (CCP) qualified fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e26bdc54a4450c93012320f8738fbb00
https://pubmed.ncbi.nlm.nih.gov/35262085
https://pubmed.ncbi.nlm.nih.gov/35262085
Autor:
Mingfei Li, Gregory R. Chiklis, Lewis E. Kazis, Ying Wang, Weiming Xia, Kim Berlo, Noureddine Melikechi
Publikováno v:
Scientific Reports
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Determining the sustainability of antibodies targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential for predicting immune response against the Coronavirus disease 2019 (COVID-19). To quantify the antibody decay rates amon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d08f1fa4896af1936e1afade1e4c8a10
http://europepmc.org/articles/PMC8373894
http://europepmc.org/articles/PMC8373894
Autor:
Kishor M. Wasan, Verica Risovic, Daniel P. Rossignol, Olena Sivak, Gregory R. Chiklis, Stephen Lee, Melvyn Lynn, Jim McShane, Nancy Wong, Douglas X. Mason
Publikováno v:
Pharmaceutical Research. 25:176-182
Eritoran (E5564) is a glycophospholipid that acts as a toll-like receptor 4 (TLR4) antagonist that is being tested as a treatment for severe sepsis and septic shock. In the blood, eritoran binds to plasma lipoproteins altering its pharmacokinetic and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f94b0f47e3c64b3fd268cbdca2188cbc
https://doi.org/10.1007/s11095-007-9428-8
https://doi.org/10.1007/s11095-007-9428-8
Autor:
Jay M, Lieberman, Whei-Kuo, Wu, Gregory R, Chiklis, Steven, Visuri, Rod, Hise, Elliot L, Rank, Paul, Casey
Publikováno v:
MLO: medical laboratory observer. 42(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0a43a223efca39536852992cabeb590e
https://pubmed.ncbi.nlm.nih.gov/20929168
https://pubmed.ncbi.nlm.nih.gov/20929168